Lloyd A. Rowland
2022
In 2022, Lloyd A. Rowland earned a total compensation of $1.2M as Senior Vice President, at CytomX Therapeutics, a 15% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $178,525 |
|---|---|
| Option Awards | $467,748 |
| Salary | $425,193 |
| Stock Awards | $128,700 |
| Other | $5,000 |
| Total | $1,205,166 |
Rowland received $467.7K in option awards, accounting for 39% of the total pay in 2022.
Rowland also received $178.5K in non-equity incentive plan, $425.2K in salary, $128.7K in stock awards and $5K in other compensation.
Rankings
In 2022, Lloyd A. Rowland's compensation ranked 2,670th out of 5,760 executives tracked by ExecPay. In other words, Rowland earned more than 53.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,670 out of 5,760 | 54th |
Division Manufacturing | 1,485 out of 3,136 | 53rd |
Major group Chemicals And Allied Products | 682 out of 1,422 | 52nd |
Industry group Drugs | 635 out of 1,323 | 52nd |
Industry Pharmaceutical Preparations | 459 out of 969 | 53rd |
Source: SEC filing on April 27, 2023.
Rowland's colleagues
We found four more compensation records of executives who worked with Lloyd A. Rowland at CytomX Therapeutics in 2022.